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Abstract
Background: Several diseases affect bone healing and physiology. Many drugs that are commonly used in
orthopaedics as "analgesics" or anti-inflammatory agents impair bone healing. Stressful conditions are
associated with decreased serum osteocalcin concentration. High endorphin levels alter calcium
metabolism, blocking the membrane channels by which calcium normally enters cells. The consequent
decrease of intracellular calcium impairs the activities of calcium-related enzymes. Naloxone is a pure
opioid antagonist. Morphine-induced osteocalcin inhibition was abolished when osteoblasts were
incubated with naloxone. Naloxone restored the altered cellular and tissue physiology by removing β-
endorphins from specific receptors. However, this is only possible if the circulating Ca concentration is
adequate. The aim of the present study was to evaluate the efficacy of parenteral naloxone administration
in inducing fast mineralization and callus remodelling in a group of sheep with a standardised bone lesion.
Methods: Twenty ewes were randomly assigned to 4 treatment groups. Group A acted as control, group
B received a solution of calcium gluconate, group C a solution of naloxone, and group D a solution of
calcium gluconate and naloxone. A transverse hole was drilled in the left metacarpus, including both
cortices, then parenteral treatment was administered intramuscularly, daily for four weeks. Healing was
evaluated by weekly radiographic examination for eight weeks. For quantitative evaluation, the ratio of the
radiographic bone density between the drill area and the adjacent cortical bone was calculated. After eight
weeks the sheep were slaughtered and a sample of bone was collected for histopathology
Results: Group D showed a higher radiographic ratio than the other groups. Sheep not treated with
naloxone showed a persistently lower ratio in the lateral than the medial cortex (P < 0.01). Histopathology
of bone samples showed more caverns and fewer osteoblasts in group D than in the other groups (P ≤
0.001).
Conclusion: A low-dose parenteral regimen of naloxone enhances mineralization and remodelling of the
callus in healing cortical defects in sheep, especially if associated with calcium gluconate.
Published: 22 May 2007
BMC Musculoskeletal Disorders 2007, 8:43 doi:10.1186/1471-2474-8-43
Received: 18 October 2006
Accepted: 22 May 2007
This article is available from: http://www.biomedcentral.com/1471-2474/8/43
© 2007 Petrizzi et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Musculoskeletal Disorders 2007, 8:43 http://www.biomedcentral.com/1471-2474/8/43
Page 2 of 9
(page number not for citation purposes)
Background
Several diseases, including metabolic, neoplastic and
infectious conditions, affect bone healing and bone phys-
iology, and many drugs that are commonly used in ortho-
paedics as "analgesics" or anti-inflammatory agents
impair bone healing [1]. The rate of healing is an impor-
tant factor in the success of treatments for bone diseases:
the faster the healing takes place in orthopaedic implants,
the less time there is to fatigue the implant system and
cause premature loosening or failure [2-4].
Recent studies have considered the effect of metabolic
stress on bone physiology [5-7]. Stressful conditions asso-
ciated with tissue injury are associated with decreased
serum osteocalcin concentration [8]. It has also been sug-
gested that high endorphin levels in situations of stress or
pain can alter calcium metabolism, blocking the mem-
brane channels by which calcium normally enters cells
[9]. The consequent decrease of intracellular calcium
impairs the activities of calcium-related enzymes.
In previous studies, opioid receptors were detected in
human osteoblasts, and the effects of different opioid ago-
nists on osteocalcin secretion were tested. Osteocalcin
synthesis in particular was significantly inhibited by high
concentration of morphine and enkephalin [10]. Osteo-
calcin induces hypocalcemia and its effect on bone is
enhancing mineralization and growth [11].
Naloxone is a pure opioid antagonist and blocks each of
the opioid receptor types [9]. Morphine-induced osteocal-
cin inhibition was abolished when osteoblasts were incu-
bated concurrently with naloxone [10]. It was shown that
naloxone restores the functional activity of cells and tissue
by removing β-endorphins from specific receptors. How-
ever, these functions are possible only if the circulating Ca
concentration is adequate [12].
It also was concluded that a low-dose parenteral regimen
with naloxone can relieve pain by a central pathway
mechanism [13]. Naloxone reportedly produces either an
increase in clinical pain or a dose-dependent biphasic
change: pain intensity increases at high doses and
decreases at low doses. Doses of naloxone lower than 1
mg/kg produced a significant decrease in pain intensity in
humans and animal models [14-17]. Since analgesia
occurs only with low doses, the effect appears to be very
specific.
Diagnostic imaging techniques are currently used to eval-
uate bone healing, particularly radiography but also ultra-
sonography [18]. A disadvantage of ultrasonography is
that the examination is considered operator-dependent;
in fracture cases, the area to be examined is relatively com-
plex and large, and the investigation is demanding on the
examiner's ability [19].
Creating a bone defect experimentally is a widespread
method for evaluating bone healing [19,20]. The evalua-
tion is usually performed with diagnostic imaging systems
during the study and/or with histomorphometric evalua-
tion at the end [20]. The time for collecting samples for
histomorphometry is usually related to the expected heal-
ing time of the defect. In contrast to other models, a "drill
hole" model system in a long bone offers the advantage of
creating a bilateral cortical defect with minimal trauma;
the number and sizes of the defects should be such as to
avoid loss of bone stability, to create a protected environ-
ment in which the only factors influencing healing are
those under investigation.
The aim of this study was to evaluate the efficacy of
parenteral naloxone administration in inducing fast min-
eralization and callus remodelling in a group of sheep
with a standardised bone lesion. Calcium gluconate was
expected to increase the extracelluar and intracellular con-
centrations of calcium, improving the activities of cal-
cium-related enzymes in these cells.
Methods
Twenty Italian Appenninica sheep, non-pregnant females
aged 2–4 years (mean 30 ± 5.2 months) and of 48–64 kg
body weight (mean 54.2 +/- 4.8 kg), were selected for this
study. The animals were all healthy as judged by clinical
and hemato-biochemical evaluations. One week before
surgery the animals were dewormed with 200 μg/kg of
ivermectin intramuscularly (im) (Ivomec ovini, Merial
Italia, Milano, Italy). The animal protocol was authorized
by the National Government agency responsible for ani-
mal welfare and protection (n 001/2001).
Pre-surgical evaluation
Before surgery (T0), every animal was subjected to clinical
orthopaedic evaluation and dorso-palmar and latero-
medial radiographic views of the left metacarpus were
obtained (90 KW, 100 mA, 0.26 s).
Surgery
General anaesthesia was induced with a single dose of 0.2
mg/kg xylazine chloride (Rompun, Bayer, AG Leverkusen,
Germany) and 10 mg/kg ketamine chloride (Ketavet 100,
Intervet Italia srl, Milano, Italy), given intramuscularly.
Thereafter, the sheep were intubated and anaesthesia was
maintained using isofluorane (Isoba, Schering Plough
Animal Health, Harefield, UK) in oxygen. A ruminal rino-
gastric tube was placed to avoid tympany during surgery.
The sheep were placed in lateral recumbency and the
proximal third of the left metacarpal bone was prepared
for aseptic surgery.BMC Musculoskeletal Disorders 2007, 8:43 http://www.biomedcentral.com/1471-2474/8/43
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A 2 cm vertical incision was made through the skin and
down to the bone at the proximo-medial aspect of the left
metacarpal bone, about 4 cm distal to the carpo-metacar-
pal joint. Then a 4 mm wide hole was drilled transversely
through both the medial and the lateral cortices of the
bone; the periosteum was removed with the drill bit from
both sides of the metacarpus. The bone debris was flushed
out of the hole with sterile saline. The skin was closed with
simple interrupted sutures.
Treatment
After surgery the sheep were randomly assigned to one of
four treatment groups (A, B, C, D), each comprising five
animals. The treatment in every group was administered
im, over 24 h, for four weeks (T1-T5). Group A (control)
received 0.1 ml/kg of 0.9% NaCl, group B (calcium group)
0.1 ml/kg of 20% calcium gluconate (Calcio ph, Fatro,
Ozzano Emilia, Italy), group C (naloxone group) 0.1 ml/
kg of 0.02% naloxone (Naloxone hydrochloride, Dyosint,
Amsterdam, Holland) and group D (calcium-naloxone
group) 0.1 ml/kg of solution containing 0.02% naloxone
and 20% calcium gluconate. A 4-week treatment was used
because bone is mostly resorbed during the first 3–4
weeks and little new bone is produced in a 4 mm cortical
defect [19]. The naloxone dosage chosen (0.02 mg/kg) is
consistent with that reported to have an analgesic effect
[14-17].
All the sheep were treated with amoxicillin (20 mg/kg q
12 h, im) (Clamoxyl RTU, Pfizer Italia, Roma, Italy) for
three days after surgery. They were allowed to recover in
large stalls with immediate ambulation; no bandage was
applied over the operated limb.
Post-operative evaluation
The animals were evaluated clinically every day to deter-
mine general condition and lameness. Lameness was eval-
uated by observing each animal moving freely in the stall
and was scored on a 4 degree scale. Bone healing was fol-
lowed in each animal by radiographic evaluation immedi-
ately after surgery (T1) and every week thereafter for 8
weeks (T2-T9) using the same technique as at T0. Thereaf-
ter, every radiographic picture was scanned (Duoscan
T1200 flatbed scanner, Agfa Italia, Milano, Italy) and
processed using graphic software (Corel Photo-Paint®
CorelDraw, Microsoft Italia, Segrate, Italy). A total area
10500 pixels (70 × 150 h) was selected, over both the
medial and the lateral cortices at the site of drilling and
over the normal adjacent bone. A histogram of the area
was then obtained by measuring the number of pixels
with each of the 256 levels of grey, ranging from white
(255) to black (0). The mean level of grey, with standard
deviation, was obtained for each area. Only the dorso-pal-
mar views could be evaluated adequately with the compu-
ter-assisted system because the superimposition of the
lateral and medial cortical defects was incomplete and
variable, and it was impossible to evaluate the healing of
the medial and lateral cortices separately in the latero-
medial views.
For each dorso-palmar radiograph, four histograms were
obtained: normal medial cortex (NMC), normal lateral
cortex (NLC), medial cortex (MCDS) and lateral cortex at
the drilling site (LCDS) (Figure 1). The LCDS/NLC and
MCDS/NMC ratios were calculated to evaluate the bone
remodelling. These ratios were also used for statistical
tests.
Histopathological evaluation
After eight weeks (T9) all the sheep were slaughtered and
a sample of bone, 2 cm long, was cut transversely from the
left metacarpal directly at the surgical drilling site. The
slice of bone obtained was then divided axially into two
parts, lateral and medial. All the samples were immedi-
ately stored in 4% buffered formalin at 4°C until further
processing as non-decalcified bone specimens. Before cut-
ting the final slices of bone the samples were embedded in
acrylic resin [21]. Briefly, after a series of steps of alcohol
dehydration and defatting with xylene, the specimens
were infiltrated and embedded in methylmethacrylate
(HistoDur®, Leica, Switzerland). The slices were cut per-
pendicularly to the drill hole axis; only cortical slices were
selected for histopathological examination. Histopathol-
ogy was used to evaluate mineralization and callus
remodelling; as the surrounding bone is highly involved
in callus remodelling, only transverse sections could show
all the cortical bone surrounding the defect.
Three kinds of evaluation were performed: qualitative,
quantitative and semi-quantitative. The qualitative and
the semiquantitative evaluations were performed using 5
μm sections prepared with a microtome (Leica SP 1400,
Wetzlar, Germany) and stained with Toluidine blue or
von Kossa/MacNeal. The slides were examined with a
light microscope (Leica DMR) at different magnifications
(10×, 20× and 40×). For the semiquantitative evaluation
the following variables were considered: presence of cav-
erns (remodelling space) in the bone surrounding the
drill hole; numbers of osteoblasts and osteoclasts; and the
appearance of mesenchymal cells and macrophages and
the presence of fibrous tissue or cartilage inside the drill
hole. Each evaluation was scored on a 4-point scale (0–3)
of increasing quantity/number (Table 1).
For quantitative evaluation, ground sections were pre-
pared. Bone samples were cut using a sawing microtome
(Leica SP 1600, Wetzlar, Germany) and mounted on
acropal plastic slides (Perspex GS opal acrylic glass 1013,
Wachendorf AG, Switzerland). After grinding and polish-
ing to approximately 30–40 μm (Struers, Birmensdorf,BMC Musculoskeletal Disorders 2007, 8:43 http://www.biomedcentral.com/1471-2474/8/43
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Switzerland), they were surface-stained with toluidine
blue. New bone formation, parent bone and fibrous tissue
within and around the "drill hole" were quantified using
an image analysis system (LeicaQWin, Leica Imaging Sys-
tems, Cambrige, England) coupled to a light microscope
(5.8-fold magnification, Leica M420) with a digital cam-
era (Leica DC200, Wetzlar, Germany). The digitalized res-
olution was 1 pixel per 8.93 μm. The optical reference was
a standardized area of 49.9 mm2 (corresponding to an 8
mm diameter) overlying the defect. Bone area and void
area were encircled on the computer by a person blinded
to the experimental groups. The amounts of new bone,
parent bone and fibrous tissue were expressed as fractions
of the total measured area.
Statistics
To evaluate the efficacy of the proposed treatments, the
results from each group, including the radiographic ratios
and histopathology, were compared statistically. Normal
distribution of data was previously assessed by means of
Kolmogorov-Smirnov test (SPSS 13.0 for Windows SPSS
inc).
The radiographic ratio data appeared normally distrib-
uted, therefore parametric statistic was applied; data were
evaluated by multiple pairwise comparisons for One-Way
layout design tests such as ANOVA and the Tukey Test
(Koichi Yoshioca® KyPlot version 2.0); repeated measures
ANOVA was also performed using SPSS Manova (SPSS
13.0 for Windows SPSS inc). The correlation between the
radiographic ratios of the medial and lateral cortices was
assessed by linear regression and Pearson Product
Moment Correlation (Microsoft® Excel 2002).
The histopathological evaluation results were estimated
by two nonparametric tests for unpaired data, the Kruskal-
Wallis Test and the Wilcoxon Rank Sum Test (Mann-Whit-
ney U Test) (Koichi Yoshioca® KyPlot version 2.0).
Differences were considered significant at P values < 0.05.
Results
Surgery
All the sheep recovered from anaesthesia; the surgical pro-
cedure was simple and no complications occurred. After
surgery only mild lameness was observed. Some swelling
developed over the surgical site in all the animals but
resolved within five days. By the second day after surgery,
all the sheep were weight-bearing on the operated limb.
One sheep in group C (naloxone) died on day 25 for
causes unrelated to the experimental protocol (grain over-
load and metabolic acidosis). Nevertheless a specimen of
bone was collected from the left metacarpus at the surgical
site. It was used for morphological evaluation like the
Dorso-palmar radiograph of the metacarpus of one sheep  (A5) after surgery (T1): selection of an area of 10500 pixels  (70 × 150 h), indicated by the red dotted line, over the  medial and lateral cortices, at the drill site (MCDS, LCDS)  and on the adjacent normal bone (NMC, NLC), to be proc- essed by graphic software (Corel Photo-Paint, CorelDraw)  to obtain the histogram for each site Figure 1
Dorso-palmar radiograph of the metacarpus of one sheep 
(A5) after surgery (T1): selection of an area of 10500 pixels 
(70 × 150 h), indicated by the red dotted line, over the 
medial and lateral cortices, at the drill site (MCDS, LCDS) 
and on the adjacent normal bone (NMC, NLC), to be proc-
essed by graphic software (Corel Photo-Paint, CorelDraw) 
to obtain the histogram for each site. The LCDS/NLC and 
MCDS/NMC ratios were calculated to evaluate bone healing 
at different times.BMC Musculoskeletal Disorders 2007, 8:43 http://www.biomedcentral.com/1471-2474/8/43
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other samples, but was excluded from the statistical eval-
uation.
Radiographic ratio
In all the animals the ratios for the lateral and medial cor-
tices were taken as 1 at T0. At T1, immediately after sur-
gery, the LCDS/NLC and MCDS/NMC ratios decreased to
a mean value of 0.91, then progressively increased in all
groups. The mean value increased to 0.97 at T5, decreased
to 0.95 at T5-T6 and then rose again until T9. The maxi-
mum value of 0.97 was reached again at T9.
The curves of the mean ratios for the lateral and medial
cortices differed. In the lateral cortex, the mean ratio rose
from 0.90 at T1 to reach a maximum of 0.95 at T5; this
decreased slightly over the subsequent measurements.
The curve for the medial cortex rose from 0.92 at T1 to
0.99 at T5, then decreased slightly, then increased further
to 0.99 at T9.
The overall curve rose slowly from 0.88 (T1) to 0.94 (T9)
in group A, and from 0.90 (T1) to 0.93 (T9) in group B,
while for groups C and D the curve was biphasic, rising
sharply from 0.91 (T1) to 0.99 (T4) and then again from
0.95 (T7) to 0.96 (T9) in group C and from 0.92 (T1) to
1.03 (T5) and again from 0.96 (T8) to 0.99 (T9) in group
D (Table 2, Figure 2).
The ratios had higher values in group D than in any other
group; the difference was significantly greater at T3 and T6
in group D than in groups A and B (P < 0.01) (Figure 3).
In groups A and B there was a persistently and signifi-
cantly (P < 0.01) lower ratio for the lateral cortex (LCDS/
NLC) than for the medial (MCDS/NMC).
Histopathology
Qualitative and semiquantitative evaluation
In all the samples the drill holes showed some degree of
ossification, although none was completely closed. New,
woven bone was established at the periphery while
fibrous tissue was still present in the centre; no cartilage or
other signs of enchondral ossification were detected.
Osteoblasts and osteoclasts were aligned along the lamel-
lae of the new bone, and caverns were found in the parent
bone surrounding the drill hole. In the samples from
group D the number of caverns (remodelling space) was
significantly higher while the number of osteoblasts was
significantly lower than in any other group (P < 0.001),
indicating an advanced stage of remodelling.
In group A (control), thin sections revealed only a few cav-
erns (grade 0.7), many osteoblasts inside the bone callus
(grade 2), and a moderate quantity of fibrous tissue (grade
1.2) (Figure 4A). In groups B (Ca) and C (Nal), the values
did not differ much from the control group except for the
number of osteoblasts (grade 1.375 in group C). Group D
specimens showed many caverns (grade 2) around the
drill hole, a moderate quantity of fibrous tissue (grade
0.9), and fewer osteoblasts inside the bone callus (grade
1) (Figure 4B). The numbers of macrophages, osteoclasts
and mesenchymal cells were similar in all groups (Table
3). Statistically, the most significant differences among
the groups were in the number of remodelling cavities and
osteoblasts.
The group C sheep that died on day 25 showed absence of
caverns (0), a moderate number of osteoblasts and osteo-
clasts (1) and much fibrous tissue (3) inside the drill hole.
Quantitative evaluation
Computerized quantitative analysis of the bone samples
obtained eight weeks after drilling the hole and four
weeks after termination of the treatment showed no statis-
tically significant difference in the percentages of new
Table 1: Correspondence of the score (0–3) for the histological findings for each parameter considered during semiquantitative 
histopathological evaluation.
Grade Surrounding Cavities Macrophages 
Mesenchymal Cells
Osteoblasts Osteoclasts Fibrous Tissue Cartilage
0 None None None None None None
1 Occupying less than 25% 
of the bone surrounding 
the drill hole
One or two cells per 
field of view within the 
drill hole
Less than 25% of the 
field of view within the 
drill hole occupied by 
cavities lined with 
osteoblasts
One or two osteoclasts 
per field of view within 
the drill hole
Less than 25% of the drill 
hole occupied by fibrous 
tissue
Less than 25% of the drill 
hole occupied by 
cartilage
2 Occupying up to 50% of 
the bone surrounding 
the drill hole
Up to five cells per field 
of view within the drill 
hole
Up to the 50 % of the 
field of view occupied by 
cavities lined with 
osteoblasts
Up to five osteoclasts 
per field of view within 
the drill hole
Up to 50% of the drill 
hole occupied by fibrous 
tissue
Up to 50% of the drill 
hole occupied by 
cartilage
3 Occupying more than 
50% of the bone 
surrounding the drill 
hole
More than five cells per 
field of view within the 
drill hole
More than 50% of the 
field of view occupied by 
cavities lined with 
osteoblasts
More than five 
osteoclasts per field of 
view within the drill hole
More than 50% of the 
drill hole occupied by 
fibrous tissue
More than 50% of the 
drill hole occupied by 
cartilage
The slides were examined with a light microscope (Leica DMR) at different magnifications (10×, 20× and 40×).BMC Musculoskeletal Disorders 2007, 8:43 http://www.biomedcentral.com/1471-2474/8/43
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bone, parent bone or fibrous tissue among the groups or
between the cortices. However, the median percentage of
fibrous tissue was higher in groups A (75.0) and B (78.9)
than in groups C (67.6) and D (71.0) (P > 0.05). The
median percentage of parent bone was higher in groups A
(6.84), B (8.45) and C (8.1) than in group D (5.0) (P >
0.05). The median percentage of new bone was lower in
groups A (18.6) and B (13.88) than in groups C (25.63)
and D (22.29) (P > 0.05).
Discussion
In this study, a low dose parenteral regimen of naloxone
was found to enhance mineralization and remodelling of
4 mm cortical defects of the metacarpal bones of sheep,
especially if the treatment was combined with calcium
gluconate administration.
The "drill hole" model proved a good system for evaluat-
ing bone healing [1,19,20]. The surgery was easy to per-
form and avoided the need for, and the influence of,
fixating devices to stabilize the fracture. Furthermore, if
the drill hole is perpendicular to the axis of the limb, as in
our case, both medial and lateral cortices can be evaluated
to detect differences in callus formation. The diameter of
the drill hole (4 mm) corresponds to what is considered a
critical-sized bone defect, which does not heal alone, at
least in the time period chosen for these experiments
[1,2,19,20]. The radiographic histogram ratio was a relia-
ble dynamic indicator of bone healing, with a low stand-
ard deviation for each mean value.
To investigate the persistence of the effect of naloxone on
bone healing and remodelling, sample collection for his-
topathology was delayed for 4 weeks after the parenteral
treatments of the sheep had ended. The number of sheep,
low for ethical and financial reasons, did not permit bone
samples to be collected at different time points after termi-
nation of the treatment. For these reasons, all the sheep
were slaughtered at the same time, 8 weeks after the begin-
ning of the experiment and 4 weeks after the end of the
various treatment modalities. The absence of cartilage or
any other sign of endochondral ossification from any of
the samples examined could be due to the lack of micro-
motion in the drill hole model, and/or to an efficient
blood supply and high oxygen tension [22].
The greatest increase in radiographic ratio after surgery
was found in the sheep treated with calcium gluconate
and naloxone (group D) (Figure 3). In the group treated
with naloxone alone (C), the increase was higher than in
the other groups (A and B), but not as high as in group D.
The differences between the radiographic ratios at T3 and
T6 were statistically significant for group D, and also for
groups A and B. This means that two weeks after the
beginning (T3) and one week after the end (T6) of treat-
ment, the drill holes were significantly more radiodense
in the sheep receiving naloxone together with calcium glu-
conate than in any other group. According to our results,
this effect was particularly evident two weeks after the
beginning of treatment and lasted for about one week
Table 2: Radiographic histogram ratios: mean values at each time point in each treatment group.
Time T0 T1 T2 T3 T4 T5 T6 T7 T8 T9
Group A
Mean 1.00 0.88 0.89 0.92 0.92 0.94 0.93 0.93 0.95 0.94
St. Dev. 0.00 0.04 0.04 0.03 0.05 0.03 0.05 0.06 0.06 0.09
Group B
Mean 1.00 0.90 0.91 0.92 0.90 0.93 0.93 0.92 0.94 0.93
St. Dev. 0.00 0.05 0.02 0.04 0.08 0.05 0.04 0.05 0.04 0.05
Group C
Mean 1.00 0.91 0.94 0.98 0.99 0.97 0.96 0.95 0.97 0.96
St. Dev. 0.00 0.09 0.05 0.05 0.04 0.07 0.04 0.08 0.06 0.04
Group D
Mean 1.00 0.92 0.96 0.99 0.98 1.03 1.00 1.00 0.96 0.99
St. Dev. 0.00 0.05 0.06 0.04 0.06 0.11 0.04 0.11 0.10 0.07BMC Musculoskeletal Disorders 2007, 8:43 http://www.biomedcentral.com/1471-2474/8/43
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after the end. These findings support the hypothesis that a
low-dose parenteral naloxone regimen enhances the min-
eralization of the callus, especially when combined with
calcium gluconate administration. As shown in previous
studies, the calcium-related activities of the cells could be
increased because the intracellular calcium is increased by
the action of naloxone on the membrane pumps [9].
Extracellular calcium is also thought to enhance the
increase in naloxone-induced intracellular calcium in a
dose-dependent manner [23]. In our study the sheep
receiving both calcium and naloxone had the highest
ratios.
In the animals treated with naloxone alone (group C), or
with naloxone together with calcium gluconate (group
D), there was no difference in the increase of radiodensity
between the lateral and medial cortical defects. In the
other groups (A and B) the lateral cortex healed signifi-
cantly more slowly than the medial. The different healing
pattern might be caused by the medial access of surgery,
irritating the periosteum and surrounding tissue and lead-
ing to an activated tissue response; in this case the effect
would have been evident in every group. The difference in
healing pattern may also be attributed to mechanical fac-
tors or different vascular supplies [24-26]. It may be
assumed that the limbs of the sheep receiving the low-
dose naloxone regimen had better and more balanced
weight-bearing and/or better perfusion, enhancing the
healing of the lateral cortex [14-17]. Decreased pain per-
ception after surgery and better subsequent mechanical
stimulation through increased weight-bearing by the
limbs may improve vascularisation and thus the healing
of the bone. However, it is difficult for the observer to
judge recognition and perception of pain in sheep [27],
and this could explain the lack of evident difference in
clinical response among the treatment groups after sur-
gery, despite the administration to two groups (C and D)
of a naloxone regimen that had shown an analgesic effect
in previous studies [10,13-17]. The clinical observation of
weight-bearing proved inadequate for pain assessment in
sheep after surgery. To answer these questions, more
objective data should be obtained in future studies for
either mechanical load (treadmill) or vascularisation
(immunohistochemistry) after naloxone application.
The analgesic properties of naloxone could reduce pain
perception from the operated limb and improve its use
[14-17,28]; previous studies [24-26] have demonstrated
that early mechanical load over a fractured limb improves
bone healing and quality of callus, enhancing microvas-
cularization [25]. Several experimental studies on animal
models and human patients have confirmed the pain-
relieving effect of low-dose naloxone (lower than 1 mg/
kg) [14-17,28], but no data are available in the literature
on the use of naloxone for fracture patients.
Qualitative histopathological examination of the samples
showed more bone caverns (P < 0.001) and lower cellu-
Comparison of a dorsopalmar radiography of the metacarpus  of a sheep from Group A (control) and one of Group D  (naloxone and calcium gluconate) at T6 Figure 3
Comparison of a dorsopalmar radiography of the metacarpus 
of a sheep from Group A (control) and one of Group D 
(naloxone and calcium gluconate) at T6. The difference in 
radiodensity at the drill hole site is evident and is statistically 
significant.
Radiographic histogram ratios: mean values at each time  point in each treatment group Figure 2
Radiographic histogram ratios: mean values at each time 
point in each treatment group.
T0
T1
T2
T3
T4
T5
T6
T7
T8
T9
G
r
o
u
p
A
G
r
o
u
p
B
G
r
o
u
p
C
G
r
o
u
p
D
0,80
0,85
0,90
0,95
1,00
1,05
time
r
a
d
i
o
g
r
a
p
h
i
c
h
i
s
t
o
g
r
a
m
r
a
t
i
o
sBMC Musculoskeletal Disorders 2007, 8:43 http://www.biomedcentral.com/1471-2474/8/43
Page 8 of 9
(page number not for citation purposes)
larity around the drill hole in group D; both findings are
compatible with a more advanced stage of bone healing
and remodelling. No statistically significant differences
could be demonstrated between groups by quantitative
evaluation. Nevertheless, in the samples from groups C
and D, both treated with naloxone, there was evidence of
more new bone and less fibrous tissue and parent bone
than in the other groups. The lack of significance could be
related to the low numbers of animals per group, the high
individual variability and/or the relatively long time
period between cessation of treatment and sacrifice.
A number of limitations must be noted in this study. Pri-
marily we have to consider the low number of animals,
chosen to satisfy ethical concerns and limited by the law.
Nonetheless, we obtained statistically significant differ-
ences in radiographic ratios and qualitative histopatho-
logical evaluation.
On the basis of our results, a histomorphological evalua-
tion of bone samples collected 2 weeks after the beginning
and one week after the cessation of a 4-week treatment
with naloxone and calcium gluconate would be interest-
ing; these are the time points at which statistically signifi-
cant differences in the radiographic ratios were detected.
Such a study would confirm the enhancement of the min-
eralization of the cortical defect
Conclusion
In conclusion, this study shows that a low-dose parenteral
regimen of naloxone, especially if associated with calcium
gluconate, aids mineralization and enhances earlier
remodelling of the cortical bone in a 4 mm drill hole
model system. Further studies are needed to establish the
effects of frequency and overall length of the treatment. A
segmental osteotomy model could also permit the effects
of naloxone alone and in association with calcium gluco-
nate to be evaluated in a mechanically unstable environ-
ment.
Semiquantitave histopathological evaluation of the samples  obtained after eight weeks from surgery Figure 4
Semiquantitave histopathological evaluation of the samples 
obtained after eight weeks from surgery. (A) Microphoto-
graph (10 ×; Toluidine Blue) of a slide obtained from a sheep 
of group A (Control); (B) Microphotograph (10 ×; Toluidine 
Blue) of a slide obtained from a sheep of group D (Naloxon 
and Calcium gluconate). Comparing the images is particularly 
evident the diffence in the number and area of the caverns 
surrounding the "drill hole" a. Parent bone; b. New bone; c. 
Fibrous tissue.
Table 3: Semiquantitative evaluation scores of the samples obtained from each cortex of every animal.
Score after semiquantitative evaluation
Group Cavities Macrophages Osteoblasts Osteoclasts Fibrous t. Mesen. Cel.
AM e a n 0.70 0.50 2.00 1.20 1.20 0.40
St. dev. 0.82 0.71 0.00 0.42 0.63 0.70
BM e a n 0.00 0.20 2.00 1.00 1.70 0.60
St. dev. 0.00 0.42 0.00 0.00 0.67 0.52
CM e a n 0.63 0.38 1.38 0.75 1.63 0.88
St. dev. 0.92 0.52 0.52 0.46 0.74 0.35
DM e a n 2.00 0.10 1.00 0.70 0.90 0.40
St. dev. 0.94 0.32 0.00 0.48 0.74 0.52
The parameters evaluated were number of remodelling cavities, presence of macrophages, number of osteoblasts and osteoclasts, quantity of 
fibrous tissue and presence of mesenchymal cells. Evaluation scores refer to 4 grades (0–3) of increasing quantity/number.BMC Musculoskeletal Disorders 2007, 8:43 http://www.biomedcentral.com/1471-2474/8/43
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